The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment
- PMID: 2021561
- DOI: 10.1111/j.1471-0528.1991.tb13387.x
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment
Abstract
The purpose of the study was to determine if reduction of pregnancy hypertension to normal prevented the clinical maternal manifestations of pre-eclampsia. Thirty-six women with hypertension, but without proteinuria, were allotted at random to a test group of 17 who received intensive treatment, and a control group of 19 who were managed according to routine methods by hospital staff unconnected with the study. The development of proteinuria was chosen as an indicator of pre-eclampsia. Proteinuria developed significantly more often in the control group (in six of the 19 women) than in the test group (in one of the 17 women).
Similar articles
-
Fetal outcome in trial of antihypertensive treatment in pregnancy.Lancet. 1976 Oct 9;2(7989):753-6. doi: 10.1016/s0140-6736(76)90597-3. Lancet. 1976. PMID: 61439 Clinical Trial.
-
Controlled trial of hypotensive agents in hypertension in pregnancy.Br Heart J. 1968 Nov;30(6):871. Br Heart J. 1968. PMID: 4888042 Clinical Trial. No abstract available.
-
Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester?Hypertens Pregnancy. 2002;21(2):161-74. doi: 10.1081/PRG-120013785. Hypertens Pregnancy. 2002. PMID: 12175444
-
The use of antihypertensive drugs in hypertension in pregnancy.Clin Obstet Gynaecol. 1977 Dec;4(3):685-705. Clin Obstet Gynaecol. 1977. PMID: 23234 Review. No abstract available.
-
[Methyldopa in therapy of hypertension in pregnant women].Ginekol Pol. 2004 Feb;75(2):160-5. Ginekol Pol. 2004. PMID: 15108591 Review. Polish.
Cited by
-
Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis.Hypertens Res. 2022 May;45(5):887-899. doi: 10.1038/s41440-022-00853-z. Epub 2022 Feb 8. Hypertens Res. 2022. PMID: 35136186
-
Hypertension in pregnancy.J Natl Med Assoc. 1994 Apr;86(4):289-93. J Natl Med Assoc. 1994. PMID: 8040904 Free PMC article. Review.
-
Oral beta-blockers for mild to moderate hypertension during pregnancy.Cochrane Database Syst Rev. 2000;2003(4):CD002863. doi: 10.1002/14651858.CD002863. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2003;(3):CD002863. doi: 10.1002/14651858.CD002863. PMID: 11034777 Free PMC article. Updated.
-
Blood pressure-lowering treatment for pregnant women with non-severe hypertension: a systematic review and meta-analysis.Hypertens Res. 2025 Aug;48(8):2152-2162. doi: 10.1038/s41440-025-02239-3. Epub 2025 May 23. Hypertens Res. 2025. PMID: 40410291 Review.
-
Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.Drugs. 1991 Sep;42(3):468-510. doi: 10.2165/00003495-199142030-00007. Drugs. 1991. PMID: 1720383 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical